Kristina Masson

A Potent and Selective Quinoxalinone-Based STK33 Inhibitor Does Not Show Synthetic Lethality in KRAS-Dependent Cells

Michel Weïwer, James Spoonamore, Jingqiang Wei et al. · ACS Medicinal Chemistry Letters · 2012 · 147 citations · Full text

Medicine, Oncology, Pharmacology +15

A novel molecular mechanism of primary resistance to FLT3-kinase inhibitors in AML

Frank Breitenbuecher, Boyka Markova, Stefan Kasper et al. · Blood · 2009 · 123 citations

Medicine, Oncology, Pharmacology +16

Direct binding of Cbl to Tyr568 and Tyr936 of the stem cell factor receptor/c-Kit is required for ligand-induced ubiquitination, internalization and degradation

Kristina Masson, Hamid Band, Lars Rönnstrand · Biochemical Journal · 2006 · 100 citations · Full text

Life Sciences, Cell Biology, Molecular Biology +16

STK33 kinase inhibitor BRD-8899 has no effect on KRAS-dependent cancer cell viability

Tuoping Luo, Kristina Masson, Jacob D. Jaffe et al. · Proceedings of the National Academy of Sciences · 2012 · 94 citations · Full text

Medicine, Molecular Biology, Oncology +13

Identification of Y589 and Y599 in the juxtamembrane domain of Flt3 as ligand-induced autophosphorylation sites involved in binding of Src family kinases and the protein tyrosine phosphatase SHP2

Kristina Masson, Christina Sundberg, Malin Pedersen et al. · Blood · 2006 · 79 citations · Full text

Life Sciences, Biochemistry, Molecular Biology +16